The β-elemene sensitizes glioblastoma cells to cisplatin through GMF-β activation [38], as the high GMF-β and p38MAPK activation enhances the killing efficacy of cisplatin in glioblastoma cells [38]. Here, GMFB is linked to glioblastoma.